{"product_id":"off-label-drugs-initial-results-of-a-national-survey-pemd-91-12br-9781289057398","title":"Off-Label Drugs: Initial Results of a National Survey: PEMD-91-12BR","description":"\u003cp\u003e • Author(s): U. S. Government Accountability Office (\u003cbr\u003e • Publisher: Bibliogov\u003cbr\u003e • Publisher Imprint: Bibliogov\u003cbr\u003e • BISAC: General\u003c\/p\u003e\u003cp\u003ePursuant to a congressional request, GAO provided information about its survey of a nationally representative sample of oncologists to determine the extent to which health insurers denied patients reimbursement for off-label drug use, focusing on: (1) the prevalence of off-label drug use, and how its use varied by clinical, demographic, and geographic factors; (2) the extent to which third-party payers denied payment for such use; and (3) whether third-party payers' policies influenced the treatment of cancer patients. \u003cbr\u003e \u003cbr\u003e GAO presented a copy of the questionnaire it mailed to the random sample of oncologists, with the number or percentage of respondents answering each item. GAO noted that it received a 56-percent response rate to its mailing of 1,470 questionnaires.\u003c\/p\u003e","brand":"Bibliogov","offers":[{"title":"Paperback","offer_id":47596674547863,"sku":"9781289057398","price":1432.0,"currency_code":"INR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0666\/3471\/1191\/files\/9781289057398.webp?v=1774994712","url":"https:\/\/atlanticbooks.com\/products\/off-label-drugs-initial-results-of-a-national-survey-pemd-91-12br-9781289057398","provider":"Atlantic Books","version":"1.0","type":"link"}